Alexandria Real Estate Equities
ARE
$115.58
Share price
-0.79%
Change (1 day)
-6.33%
Change (1 year)
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.
Alexandria Real Estate Equities (ARE) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $14.14 B
According to Alexandria Real Estate Equities 's latest financial reports the company's total liabilities are $14.14 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Alexandria Real Estate Equities - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $14.14 B | 10.19% |
| 2022-12-31 | $12.84 B | 14.79% |
| 2021-12-31 | $11.18 B | 19.2% |
| 2020-12-31 | $9.38 B | 14.11% |
| 2019-12-31 | $8.22 B | 25.17% |
| 2018-12-31 | $6.57 B | 16.89% |
| 2017-12-31 | $5.62 B | 13.03% |
| 2016-12-31 | $4.97 B | 8.41% |
| 2015-12-31 | $4.58 B | 8.53% |
| 2014-12-31 | $4.22 B | 19.03% |
| 2013-12-31 | $3.55 B | -2.64% |
| 2012-12-31 | $3.64 B | 16.1% |
| 2011-12-31 | $3.14 B | 7.59% |
| 2010-12-31 | $2.91 B | -4.31% |
| 2009-12-31 | $3.05 B | -10.02% |
| 2008-12-31 | $3.39 B | 8.05% |
| 2007-12-31 | $3.13 B | 42.11% |
| 2006-12-31 | $2.20 B | 46% |
| 2005-12-31 | $1.51 B | 20.83% |
| 2004-12-31 | $1.25 B | 63.54% |
| 2003-12-31 | $0.76 B | 13.67% |
| 2002-12-31 | $0.67 B | 6.97% |
| 2001-12-31 | $0.62 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 869.81% | 🇺🇸 USA |
 Eli Lilly LLY | $53.14 B | 275.61% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 542.63% | 🇺🇸 USA |
 Gilead Sciences GILD | $39.37 B | 178.31% | 🇺🇸 USA |
 Illumina ILMN | $4.36 B | -69.14% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $65.67 B | 364.18% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $4.05 B | -71.37% | 🇺🇸 USA |